Smith & Nephew burns indication for Versajet:
This article was originally published in Clinica
The US FDA has given Smith & Nephew 510(k) market clearance to expand the use of its hydrosurgery debridement system to the treatment of burns. The Versajet device is a waterjet-powered system that enables surgeons to simultaneously grasp, cut and remove damaged tissue and contaminants precisely, without collateral tissue damage associated with current surgical treatment methods, claims the firm. It was previously cleared for removing dead tissue from a wide variety of other wounds, including chronic and acute wounds. "The expansion of Versajet's labelling provides another avenue of growth for Smith & Nephew," said Joe Woody, president of the firm's Hull, UK-based advanced wound management division.